These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 36535779

  • 21. Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA.
    Yang Y, Chen W, Pan Y, Yan H, Meng X, Liu L, Wang Y, Wang Y.
    Aging (Albany NY); 2020 Oct 16; 12(20):20085-20094. PubMed ID: 33065552
    [Abstract] [Full Text] [Related]

  • 22. Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial.
    Xie X, Jing J, Meng X, Johnston SC, Bath PM, Li Z, Zhao X, Wang Y, Xu Q, Wang A, Jiang Y, Li H, Wang Y, CHANCE-2 Investigators.
    Stroke; 2024 Jul 16; 55(7):1739-1747. PubMed ID: 38860396
    [Abstract] [Full Text] [Related]

  • 23. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    Wang Y, Chen W, Lin Y, Meng X, Chen G, Wang Z, Wu J, Wang D, Li J, Cao Y, Xu Y, Zhang G, Li X, Pan Y, Li H, Zhao X, Liu L, Lin J, Dong K, Jing J, Johnston SC, Wang D, Wang Y, PRINCE Protocol Steering Group.
    BMJ; 2019 Jun 06; 365():l2211. PubMed ID: 31171523
    [Abstract] [Full Text] [Related]

  • 24. Cost-effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack/minor stroke: A Canadian perspective.
    Micieli A, Singh N, Jahn B, Siebert U, Menon BK, Demchuk AM.
    Int J Stroke; 2023 Apr 06; 18(4):416-425. PubMed ID: 35739635
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Aminotransferase Level and the Effects of Dual Antiplatelet in Minor Stroke or Transient Ischemic Attack: A post hoc Analysis of a Randomized Control Trial.
    Suo Y, Pan Y, Chen W, Jing J, Yan H, Li H, Liu L, Zhao X, Wang Y, Meng X, Wang Y, CHANCE investigators.
    Cerebrovasc Dis; 2023 Apr 06; 52(4):442-450. PubMed ID: 36502795
    [Abstract] [Full Text] [Related]

  • 28. Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack.
    Wang A, Meng X, Tian X, Johnston SC, Li H, Bath PM, Zuo Y, Xie X, Jing J, Lin J, Wang Y, Zhao X, Li Z, Jiang Y, Liu L, Wang F, Li Y, Liu J, Wang Y, CHANCE-2 Investigators.
    Ann Neurol; 2022 Mar 06; 91(3):380-388. PubMed ID: 34951042
    [Abstract] [Full Text] [Related]

  • 29. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
    Hoh BL, Gong Y, McDonough CW, Waters MF, Royster AJ, Sheehan TO, Burkley B, Langaee TY, Mocco J, Zuckerman SL, Mummareddy N, Stephens ML, Ingram C, Shaffer CM, Denny JC, Brilliant MH, Kitchner TE, Linneman JG, Roden DM, Johnson JA.
    J Neurosurg; 2016 Jun 06; 124(6):1746-51. PubMed ID: 26587656
    [Abstract] [Full Text] [Related]

  • 30. Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial.
    Wang Y, Johnston C, Bath PM, Meng X, Jing J, Xie X, Wang A, Pan Y, Xu A, Dong Q, Wang Y, Zhao X, Li Z, Li H, CHANCE-2 Investigators.
    Stroke Vasc Neurol; 2021 Jun 06; 6(2):280-285. PubMed ID: 33952670
    [Abstract] [Full Text] [Related]

  • 31. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
    Li M, Yang Q, Shi J, Zhang X, Lin H, Ge F.
    BMC Neurol; 2023 Aug 14; 23(1):303. PubMed ID: 37580668
    [Abstract] [Full Text] [Related]

  • 32. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
    Pereira NL, Farkouh ME, So D, Lennon R, Geller N, Mathew V, Bell M, Bae JH, Jeong MH, Chavez I, Gordon P, Abbott JD, Cagin C, Baudhuin L, Fu YP, Goodman SG, Hasan A, Iturriaga E, Lerman A, Sidhu M, Tanguay JF, Wang L, Weinshilboum R, Welsh R, Rosenberg Y, Bailey K, Rihal C.
    JAMA; 2020 Aug 25; 324(8):761-771. PubMed ID: 32840598
    [Abstract] [Full Text] [Related]

  • 33. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
    Jing J, Meng X, Zhao X, Liu L, Wang A, Pan Y, Li H, Wang D, Johnston SC, Wang Y, Wang Y.
    JAMA Neurol; 2018 Jun 01; 75(6):711-719. PubMed ID: 29582084
    [Abstract] [Full Text] [Related]

  • 34. Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With CYP2C19 Genetic Variants.
    Lin Y, Wang A, Li J, Lin J, Wang D, Meng X, Ou L, Chen W, Zhao X, Liu L, Wang Y, Wang Y, CHANCE Investigators.
    Stroke; 2017 Apr 01; 48(4):998-1004. PubMed ID: 28289237
    [Abstract] [Full Text] [Related]

  • 35. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
    Lun R, Dhaliwal S, Zitikyte G, Roy DC, Hutton B, Dowlatshahi D.
    JAMA Neurol; 2022 Feb 01; 79(2):141-148. PubMed ID: 34870698
    [Abstract] [Full Text] [Related]

  • 36. Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial.
    Zhang XG, Zhu XQ, Xue J, Li ZZ, Jiang HY, Hu L, Yue YH.
    BMJ Open; 2019 May 22; 9(5):e028595. PubMed ID: 31123001
    [Abstract] [Full Text] [Related]

  • 37. The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients with cerebral artery stenting.
    Liu C, Liu M, Yang X, Luo T, Wang J, Li G.
    Clin Neurol Neurosurg; 2024 Apr 22; 239():108229. PubMed ID: 38479036
    [Abstract] [Full Text] [Related]

  • 38. Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA.
    Yang Y, Chen W, Pan Y, Yan H, Meng X, Liu L, Wang Y, Wang Y.
    Front Neurol; 2020 Apr 22; 11():534. PubMed ID: 32587571
    [Abstract] [Full Text] [Related]

  • 39. In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke.
    Joundi RA.
    Ann Intern Med; 2022 Mar 22; 175(3):JC30. PubMed ID: 35226525
    [Abstract] [Full Text] [Related]

  • 40. Genotype-Guided Dual Antiplatelet Use for Transient Ischemic Attack and Minor Stroke by Imaging Status: Subgroup Analysis of the CHANCE-2 Trial.
    Jing J, Xie X, Johnston SC, Bath PM, Li Z, Zhao X, Liu L, Wang Y, Xu Q, Wang A, Jiang Y, Li H, Meng X, Wang Y, CHANCE-2 Investigators.
    Ann Neurol; 2023 Apr 22; 93(4):783-792. PubMed ID: 36571569
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.